Cutaneous Leishmaniasis. Cutaneous Leishmaniasis
Conditions
Interventions
Clofazimine capsule,50-100mg/day ,orally for 3 weeks.
Treatment - Drugs
Clofazimine capsule,50-100mg/day ,orally for 3 weeks
Sponsors
Fars University of Medical Sciences and Health Services
Eligibility
Sex/Gender
All
Age
12 Years to 139 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Age more than 12 y/o, duration of disease less than 2month, no anti-leishmania (Glucantim, Rifampin, Azithromycin) treatment since 1 month prior to study, Exclusion criteria: Lesion on face and joint, pregnancy, lactation, severe diseases including hepatic, renal and cardiac diseases
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Complete healing with re-epithelialization of cutaneous lesion. Timepoint: 3 week. Method of measurement: Physical examination and change of score, including: erythema, induration, ulceration and size of lesions. | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse effect. Timepoint: 3 weeks. Method of measurement: Physical examination and medical history. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Jaber Mazandarani
Fars University of Medical sciences and Health Services
Outcome results
None listed